CHD4 Predicts Aggressiveness in PTC Patients and Promotes Cancer Stemness and EMT in PTC Cells

Chromodomain-helicase-DNA-binding protein 4 (CHD4), a core subunit of the nucleosome remodeling and deacetylation (NuRD) complex is highly expressed in several cancers. However, its role in the pathogenesis and progression of papillary thyroid carcinoma (PTC) has not been investigated. We investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pratheeshkumar, Poyil, Siraj, Abdul K., Divya, Sasidharan Padmaja, Parvathareddy, Sandeep Kumar, Alobaisi, Khadija, Al-Sobhi, Saif S., Al-Dayel, Fouad, Al-Kuraya, Khawla S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825451/
https://www.ncbi.nlm.nih.gov/pubmed/33419089
http://dx.doi.org/10.3390/ijms22020504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825451/
https://www.ncbi.nlm.nih.gov/pubmed/33419089
http://dx.doi.org/10.3390/ijms22020504

Ejemplares similares